KAZANO 12.5-500 MG TABLET

alogliptin and metformin hydrochloride
$6.5885per EA

Strength

12.5; 500 mg/1; mg/1

NDC

64764033560

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

9/18/2024

Approval Type

New Drug (NDA)

FDA Application

NDA203414

On Market Since

1/25/2013

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+10.0%

5Y

+10.0%

All

+44.1%